Prelude Therapeutics posts corporate presentation and SMARCA degrader educational series

Prelude Therapeutics Inc

Company furnished a corporate presentation (Exhibit 99.1) dated June 2024.
Launched educational video series on SMARCA degraders available via investor website.
No financial results, clinical data, or material business changes disclosed.

item 7.01 item 9.01

Prelude Therapeutics Inc filing history →

Source: SEC EDGAR

accession 0000950170-24-072249

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.